Cargando…

Evaluation of a SARS-CoV-2 Capture IgM Antibody Assay in Convalescent Sera

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is responsible for a global pandemic with over 152 million cases and 3.19 million deaths reported by early May 2021. Understanding the serological response to SARS-CoV-2 is critical to determining the burden of infection and disease (coron...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ha, Binh, Jadhao, Samadhan, Hussaini, Laila, Gibson, Theda, Stephens, Kathy, Salazar, Luis, Ciric, Caroline, Taylor, Meg, Rouphael, Nadine, Edupuganti, Srilatha, Rostad, Christina A., Tompkins, S. Mark, Anderson, Evan J., Anderson, Larry J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557898/ https://www.ncbi.nlm.nih.gov/pubmed/34494855 http://dx.doi.org/10.1128/Spectrum.00458-21

Ejemplares similares

The development and kinetics of functional antibody-dependent cell-mediated cytotoxicity (ADCC) to SARS-CoV-2 spike protein
por: Chen, Xuemin, et al.
Publicado: (2021)

1329. Burden of Respiratory Syncytial Virus (RSV) Infection among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
por: Salazar, Luis W, et al.
Publicado: (2021)

1334. Outcomes Among Influenza and SARS-CoV-2 Infection in Hospitalized Adults Age ≥ 50 Years and with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
por: Taylor, Megan, et al.
Publicado: (2021)

1340. The Burden of Influenza and Rhinovirus Among Hospitalized Adults Post the COVID-19 Pandemic
por: Reese, Olivia D, et al.
Publicado: (2021)

Detection of RSV Antibodies in Human Plasma by Enzyme Immunoassays
por: Jadhao, Samadhan J., et al.
Publicado: (2016)

260. Durability of Antibody Responses to RSV in Older Adults Following Hospitalization for Acute Respiratory Infection
por: Ciric, Caroline, et al.
Publicado: (2023)

Longitudinal Neutralizing and Functional Antibody Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Variants Following Messenger RNA Coronavirus Disease 2019 Vaccination
por: Chen, Xuemin, et al.
Publicado: (2023)

Two RSV Platforms for G, F, or G+F Proteins VLPs
por: Ha, Binh, et al.
Publicado: (2020)

2621. Social Risk Factors for RSV-related Hospitalizations in Adults ≥ 50 years of age
por: De Castro, Khalel, et al.
Publicado: (2023)

Functional Features of the Respiratory Syncytial Virus G Protein
por: Anderson, Larry J., et al.
Publicado: (2021)

2314. Burden of Respiratory Syncytial Virus (RSV) Infection Among Hospitalized Older Adults and Those with Underlying Chronic Obstructive Pulmonary Disease (COPD) or Congestive Heart Failure (CHF)
por: Anderson, Evan J, et al.
Publicado: (2019)

Comirnaty-Elicited and Convalescent Sera Recognize Different Spike Epitopes
por: Hein, Sascha, et al.
Publicado: (2021)

892. Epidemiology, clinical features, and outcomes of Rhinovirus/Enterovirus in older adults hospitalized with acute respiratory infections and those with CHF and COPD exacerbations
por: Ess, Gabby, et al.
Publicado: (2023)

Biofilm and planktonic pneumococci demonstrate disparate immunoreactivity to human convalescent sera
por: Sanchez, Carlos J, et al.
Publicado: (2011)

SARS corona virus peptides recognized by antibodies in the sera of convalescent cases
por: Guo, Jian-Ping, et al.
Publicado: (2004)

Development of an ELISA for distinguishing convalescent sera with Mycoplasma hyopneumoniae infection from hyperimmune sera responses to bacterin vaccination in pigs
por: Ding, Honglei, et al.
Publicado: (2021)

NEUTRALIZATION TESTS WITH SERA OF CONVALESCENT OR IMMUNIZED ANIMALS AND THE VIRUSES OF SWINE AND HUMAN INFLUENZA
por: Francis, Thomas, et al.
Publicado: (1936)

Sensitivity of SARS-CoV-2 antibody tests with late convalescent sera
por: Kannenberg, Judith, et al.
Publicado: (2021)

Seroepidemiologic study on convalescent sera from dengue fever patients in Jinghong, Yunnan
por: Ma, Yingshuo, et al.
Publicado: (2021)

430. Clinical Features and Outcomes of COVID-19 Hospitalized Adults by Variant
por: Perez, Maria A, et al.
Publicado: (2023)

Original antigenic sin responses to Betacoronavirus spike proteins are observed in a mouse model, but are not apparent in children following SARS-CoV-2 infection
por: Lapp, Stacey A., et al.
Publicado: (2021)

High Heterogeneity of Virus-Neutralizing and RBD-Binding Activities of COVID-19 Convalescent Sera
por: Astakhova, E. A., et al.
Publicado: (2022)

SARS-CoV-2 Antibody Profiles in Maternal Serum and Breast Milk Following mRNA COVID-19 Vaccination: A Longitudinal Prospective Observational Cohort Study
por: Hsiao, Hui-Mien, et al.
Publicado: (2023)

BACTERIOSTATIC EFFECT OF HUMAN SERA ON GROUP A STREPTOCOCCI : I. TYPE-SPECIFIC ANTIBODIES IN SERA OF PATIENTS CONVALESCING FROM GROUP A STREPTOCOCCAL PHARYNGITIS
por: Rothbard, Sidney
Publicado: (1945)

The Use of Convalescent Sera in Immune-Electron Microscopy to Detect Non-Suspected/New Viral Agents
por: Lavazza, Antonio, et al.
Publicado: (2015)

1068. Prior SARS-CoV-2 infection and risk of subsequent COVID-19-related hospitalization: a test negative design
por: Castro, Khalel De, et al.
Publicado: (2022)

1908. Social Risk Factors for COVID-19-Related Hospitalizations in Adults
por: Reese, Olivia D, et al.
Publicado: (2022)

1934. Association between Receipt of COVID-19, Influenza, and Pneumococcal Vaccination
por: Choi, Chris, et al.
Publicado: (2022)

Persistence of anti-SARS-CoV-2 IgM in convalescent COVID-19 patients
por: Yan, Xiquan, et al.
Publicado: (2021)

Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19
por: Ngo, Binh, et al.
Publicado: (2021)

Development of an indirect ELISA for detecting humoral immunodominant proteins of Mycoplasma hyopneumoniae which can discriminate between inactivated bacterin-induced hyperimmune sera and convalescent sera
por: Ding, Honglei, et al.
Publicado: (2019)

Effect of Monoclonal Antibody Treatment on Clinical Outcomes in Ambulatory Patients With Coronavirus Disease 2019
por: Anderson, Blake, et al.
Publicado: (2021)

Reproduction of contagious caprine pleuropneumonia reveals the ability of convalescent sera to reduce hydrogen peroxide production in vitro
por: Liljander, Anne, et al.
Publicado: (2019)

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
por: Hu, Jie, et al.
Publicado: (2021)

Partial resistance of SARS-CoV-2 Delta variants to vaccine-elicited antibodies and convalescent sera
por: Tada, Takuya, et al.
Publicado: (2021)

Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
por: Hu, Jie, et al.
Publicado: (2021)

Neutralization heterogeneity of circulating SARS-CoV-2 variants to sera elicited by a vaccinee or convalescent
por: Zhang, Meng, et al.
Publicado: (2022)

IgM-Linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease
por: Biasiolo, Alessandra, et al.
Publicado: (2012)

Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2
por: Gasser, Romain, et al.
Publicado: (2021)

Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19
por: Singh, Vidisha, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_vdqb7dh5in0oafmfma55lv0rql